Literature DB >> 23466815

Abdominal obesity, independent from caloric intake, accounts for the development of intestinal tumors in Apc(1638N/+) female mice.

Derek M Huffman1, Leonard H Augenlicht, Xueying Zhang, John J Lofrese, Gil Atzmon, John P Chamberland, Christos S Mantzoros.   

Abstract

To determine whether visceral fat (VF), independent of other confounders, is causally linked to intestinal tumorigenesis, we surgically removed visceral fat in Apc(1638/N+) mice. At 15 weeks of age, male and female Apc(1638/N+) mice were randomized to one of three groups: ad libitum, visceral fat removal (VF-) and ad libitum fed, or caloric restriction, and were studied for effects on tumorigenesis and survival. As compared with ad libitum, VF- and caloric restriction reduced macroadenomas to a similar extent (P < 0.05), but only caloric restriction significantly improved survival (P < 0.05). Given that a significant group × gender interaction was observed, we next examined males and females separately. In females, macroadenomas were markedly attenuated by VF- (1.33 ± 0.23 mean ± SE; P < 0.05), but not by caloric restriction (2.35 ± 0.25; P = 0.71), as compared with ad libitum (2.50 ± 0.34). In males, however, caloric restriction (1.71 ± 0.26; P < 0.01), but not VF- (2.94 ± 0.42; P = 0.29), reduced macroadenomas, as compared with ad libitum males (3.47 ± 0.30). In females, both VF- (P = 0.05) and caloric restriction (P < 0.01) improved survival, but not in male mice (P = 0.15). The benefits observed with caloric restriction were consistent with favorable metabolic adaptations, but protection conferred in VF- females was despite lower adiponectin levels (P < 0.05), and failure to reduce body mass, total adiposity, glucose, insulin, leptin, and chemokine (C-X-C motif) ligand 1 (CXCL-1) levels. In conclusion, these data provide the first causal evidence linking visceral fat to intestinal cancer risk, and suggest that factors, other than known metabolic mediators, may impact tumor development. Furthermore, these data emphasize that strategies designed to deplete visceral fat stores in humans should be considered in the prevention of intestinal cancer. Cancer Prev Res; 6(3); 177-87. ©2012 AACR. ©2012 AACR.

Entities:  

Mesh:

Year:  2013        PMID: 23466815      PMCID: PMC3595118          DOI: 10.1158/1940-6207.CAPR-12-0414

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  42 in total

1.  The effect of fat removal on glucose tolerance is depot specific in male and female mice.

Authors:  Haifei Shi; April D Strader; Stephen C Woods; Randy J Seeley
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-07-24       Impact factor: 4.310

2.  Oral contraceptives and colorectal cancer risk: a systematic review and meta-analysis.

Authors:  Cristina Bosetti; Francesca Bravi; Eva Negri; Carlo La Vecchia
Journal:  Hum Reprod Update       Date:  2009-05-04       Impact factor: 15.610

3.  Obesity accelerates mouse mammary tumor growth in the absence of ovarian hormones.

Authors:  Nomeli P Nunez; Susan N Perkins; Nicole C P Smith; David Berrigan; David M Berendes; Lyuba Varticovski; J Carl Barrett; Stephen D Hursting
Journal:  Nutr Cancer       Date:  2008       Impact factor: 2.900

4.  Tumor progression in Apc(1638N) mice with Exo1 and Fen1 deficiencies.

Authors:  M Kucherlapati; A Nguyen; M Kuraguchi; K Yang; K Fan; R Bronson; K Wei; M Lipkin; W Edelmann; R Kucherlapati
Journal:  Oncogene       Date:  2007-04-23       Impact factor: 9.867

5.  Visceral adipose tissue modulates mammalian longevity.

Authors:  Radhika Muzumdar; David B Allison; Derek M Huffman; Xiaohui Ma; Gil Atzmon; Francine H Einstein; Sigal Fishman; Aruna D Poduval; Theresa McVei; Scott W Keith; Nir Barzilai
Journal:  Aging Cell       Date:  2008-03-18       Impact factor: 9.304

Review 6.  Obesity and cancer.

Authors:  Tobias Pischon; Ute Nöthlings; Heiner Boeing
Journal:  Proc Nutr Soc       Date:  2008-05       Impact factor: 6.297

7.  Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes.

Authors:  Ruslan Novosyadlyy; Danielle E Lann; Archana Vijayakumar; Anne Rowzee; Deborah A Lazzarino; Yvonne Fierz; Joan M Carboni; Marco M Gottardis; Patricia A Pennisi; Alfredo A Molinolo; Naamit Kurshan; Wilson Mejia; Stefania Santopietro; Shoshana Yakar; Teresa L Wood; Derek LeRoith
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

Review 8.  Role of visceral adipose tissue in aging.

Authors:  Derek M Huffman; Nir Barzilai
Journal:  Biochim Biophys Acta       Date:  2009-01-31

9.  Obesity enhances gastrointestinal tumorigenesis in Apc-mutant mice.

Authors:  C Gravaghi; J Bo; K M D Laperle; F Quimby; R Kucherlapati; W Edelmann; S A Lamprecht
Journal:  Int J Obes (Lond)       Date:  2008-08-26       Impact factor: 5.095

10.  Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition.

Authors:  T Fujisawa; H Endo; A Tomimoto; M Sugiyama; H Takahashi; S Saito; M Inamori; N Nakajima; M Watanabe; N Kubota; T Yamauchi; T Kadowaki; K Wada; H Nakagama; A Nakajima
Journal:  Gut       Date:  2008-08-01       Impact factor: 23.059

View more
  24 in total

1.  Outcomes of laparoscopic sleeve gastrectomy in patients older than 60 years.

Authors:  Ido Mizrahi; Abbas Alkurd; Muhammad Ghanem; Diaa Zugayar; Haggi Mazeh; Ahmed Eid; Nahum Beglaibter; Ronit Grinbaum
Journal:  Obes Surg       Date:  2014-06       Impact factor: 4.129

2.  A role for FGF2 in visceral adiposity-associated mammary epithelial transformation.

Authors:  Vanessa Benham; Debrup Chakraborty; Blair Bullard; Jamie J Bernard
Journal:  Adipocyte       Date:  2018-03-21       Impact factor: 4.534

Review 3.  The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling.

Authors:  Wilhelm Engström; Philippa Darbre; Staffan Eriksson; Linda Gulliver; Tove Hultman; Michalis V Karamouzis; James E Klaunig; Rekha Mehta; Kim Moorwood; Thomas Sanderson; Hideko Sone; Pankaj Vadgama; Gerard Wagemaker; Andrew Ward; Neetu Singh; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Anna Maria Colacci; Monica Vaccari; Chiara Mondello; A Ivana Scovassi; Jayadev Raju; Roslida A Hamid; Lorenzo Memeo; Stefano Forte; Rabindra Roy; Jordan Woodrick; Hosni K Salem; Elizabeth P Ryan; Dustin G Brown; William H Bisson
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

Review 4.  The role of obesity in gastrointestinal cancer: evidence and opinion.

Authors:  Claire L Donohoe; Naoimh J O'Farrell; Suzanne L Doyle; John V Reynolds
Journal:  Therap Adv Gastroenterol       Date:  2014-01       Impact factor: 4.409

5.  Elucidating the role of adipose tissue secreted factors in malignant transformation.

Authors:  Debrup Chakraborty; Vanessa Benham; Jamie J Bernard
Journal:  Adipocyte       Date:  2017-11-02       Impact factor: 4.534

6.  Apc inactivation, but not obesity, synergizes with Pten deficiency to drive intestinal stem cell-derived tumorigenesis.

Authors:  Tahmineh Tabrizian; Donghai Wang; Fangxia Guan; Zunju Hu; Amanda P Beck; Fabien Delahaye; Derek M Huffman
Journal:  Endocr Relat Cancer       Date:  2017-03-28       Impact factor: 5.678

Review 7.  Obesity and cancer pathogenesis.

Authors:  Nathan A Berger
Journal:  Ann N Y Acad Sci       Date:  2014-04       Impact factor: 5.691

8.  Get the fat out!

Authors:  Natalia A Ignatenko; Eugene W Gerner
Journal:  Cancer Prev Res (Phila)       Date:  2013-03

9.  High-fat diet-activated fatty acid oxidation mediates intestinal stemness and tumorigenicity.

Authors:  Miyeko D Mana; Amanda M Hussey; Constantine N Tzouanas; Shinya Imada; Yesenia Barrera Millan; Dorukhan Bahceci; Dominic R Saiz; Anna T Webb; Caroline A Lewis; Peter Carmeliet; Maria M Mihaylova; Alex K Shalek; Ömer H Yilmaz
Journal:  Cell Rep       Date:  2021-06-08       Impact factor: 9.423

10.  Diet- and Genetically-Induced Obesity Differentially Affect the Fecal Microbiome and Metabolome in Apc1638N Mice.

Authors:  Anna C Pfalzer; Paula-Dene C Nesbeth; Laurence D Parnell; Lakshmanan K Iyer; Zhenhua Liu; Anne V Kane; C-Y Oliver Chen; Albert K Tai; Thomas A Bowman; Martin S Obin; Joel B Mason; Andrew S Greenberg; Sang-Woon Choi; Jacob Selhub; Ligi Paul; Jimmy W Crott
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.